Is the Gender Specific Risk of Ischemic Stroke in Atrial Fibrillation Related to Differences in Anticoagulation?

Sullivan, Renee M.; Zhang, Jingyang; Zamba, Gideon; Lip, Gregory Y.H.; Olshansky, Brian

doi:10.1016/s0735-1097(11)62010-x

Cited by 1 publication

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The clinical significance of sex differences in TTR has been discussed by Sullivan et al 59 who attributed this to women spending more time below the therapeutic range than men (29 ± 0.7%; 26 ± 0.5%; P = .0002), and this difference was pointed out to be partially related Patients with TTR ≥ 70% in months 4-9 (Months 4-9 are the first 6-month period after the initial 3-month period to establish a stable warfarin dose).…”

Section: Discussionmentioning

confidence: 99%

Sex‐influence on the time in therapeutic range (TTR) during oral anticoagulation with coumarin derivatives: Systematic review and meta‐analysis

Viana

Praxedes

Sousa

et al. 2021

Brit J Clinical Pharma

View full text Add to dashboard Cite

Aims: We sought to investigate the association between sex and oral anticoagulation control employing coumarin derivatives.Methods: Electronic sources were MEDLINE, Biblioteca Virtual em Saúde (BVS), The Cumulative Index to Nursing and Allied Health Literature (CINAHL), EMBASE, Cochrane Central and Web of Science. Inclusion criteria were: observational and experimental studies; age ≥18 years; both sexes; treatment with any coumarin derivative for ≥3 months; any indication of long-term use; quality of oral anticoagulation measured by time in therapeutic range (TTR). The meta-analysis was developed with odds ratios (OR) for binary variables and mean differences (MD) for continuous variables, using random-effects models (DerSimonian and Laird) with 95% confidence intervals (CI).Results: Overall, 22 articles were selected, comprising 16 cohort studies, four crosssectional studies and two clinical trials. The number of participants ranged from 110 to 104 505 (183 612; women: 45%). The main indication of oral anticoagulation was atrial fibrillation. Most studies reported the use of warfarin. In the meta-analysis, 15 studies were analysed using TTR as a binary variable (OR = 0.87; 95% CI = 0.78, 0.96; z = À2.75; P = .006.; I 2 = 67%) and seven studies as a continuous variable (MD = À2.97; 95% CI = À4.80, À1.14; z = À3.19; P = .0014; I 2 = 75%). The pooled estimates indicated that women were associated with lower TTR than men.Conclusions: Our findings revealed an association between female sex and worse oral anticoagulation control. Further studies are needed with primary design to investigate sex-related factors influencing oral anticoagulation control with coumarin derivatives. Innovative strategies focused on women's health may be useful to improve patient-centred care.

show abstract

Section: Discussionmentioning

confidence: 99%